Latest Headlines

  1. Insights Into Lyophilization Seminars
    8/28/2014

    SP Scientific, in conjunction with GILYOS GmbH, has announced the program and venues for a one day seminar designed to provide attendees scientific insights into current best practices and new research trends for the freeze drying of pharmaceuticals and biologicals.

  2. Cognex Expands 3D Sensor Portfolio
    8/28/2014

    Cognex Corporation (NASDAQ: CGNX), the world's leader in machine vision, today announced an expanded portfolio of 3D laser displacement sensors, an industrial vision controller, and powerful new 3D vision tools. 

  3. Recipharm Invests In Isofol And Chemotherapeutic Agent Modufolin
    8/28/2014

    Recipharm has announced in a press release that it has invested SEK 8 million ($1 million) in Isofol Medical AB and has agreed to collaborate on Isofol’s lead drug candidate Modufolin. The biomodulator has shown promise in increasing the efficacy of chemotherapeutic agents and decreasing the side effects.

  4. Novo Nordisk Acquires Manufacturing Facility From Olympus Biotech
    8/28/2014

    Novo Nordisk announced in a press release that it has acquired a manufacturing facility in West Lebanon, New Hampshire, from Olympus Biotech. Primarily used for mammalian cell manufacturing, all production ceased at the site early in 2014. Novo Nordisk will produce active pharmaceutical ingredients at the facility for its biopharmaceutical products. The two companies did not disclose the financial terms of the transaction.

  5. New and Updated Drug Shortages List 8/27/14
    8/28/2014

    The Food and Drug Administration has published its new and updated Drug Shortages through 8/27/14. The federal agency publicizes recalls on its website as press releases are not issued for all shortages. View the recalls by New and Updated.

  6. What You Missed From Regulatory Agencies Recently – August 18-28, 2014
    8/28/2014

    The past two weeks saw approvals and orphan drug designations for Biogen Idec, Bristol-Myers Squibb, Basilea Pharma, Cubist, and Celegene, among others.

  7. Whitehouse Labs Renews Partnership With PTI Inspection Systems
    8/28/2014

    Whitehouse Laboratories is excited to announce that it has renewed its long term partnership with PTI Inspection Systems that will enable it to continue to provide clients with state of the art leak testing method development and validation programs using the most state of the art instruments currently available.

  8. Janssen To Acquire Covagen And FynomAb Technology
    8/27/2014

    Janssen announced that its affiliate Cilag GmbH International has acquired Covagen, a biopharmaceutical form focused on developing multi-specific protein therapeutics through the FynomAb technology platform.

  9. Hera Therapeutics Presents Antiviral Drug For HPV
    8/27/2014

    Scientists from Hera Therapeutics, part of the Janssen Labs under the Johnson & Johnson’s external R&D engine, presented results suggesting that its small molecule HTI-1968 has potential as a direct-acting antiviral therapy against Human Papilloma Virus (HPV).

  10. DPx Holdings B.V. Reaches Definitive Agreement To Acquire Gallus BioPharmaceuticals
    8/27/2014

    DPx Holdings B.V., privately owned by JLL Partners and Royal DSM, is pleased to announce that it has reached a definitive agreement to acquire all shares of Gallus BioPharmaceuticals, LLC, a leading contract manufacturing company specializing in biologics and current portfolio company of Ridgemont Equity Partners. Following the transaction, Patheon’s biologic drug substance business, a unit of DPx Holdings, will span four facilities in Europe, Australia and North America and include 550 employees globally.